Crossref journal-article
Elsevier BV
Molecular & Cellular Proteomics (78)
Bibliography

Zabel, C., Chamrad, D. C., Priller, J., Woodman, B., Meyer, H. E., Bates, G. P., & Klose, J. (2002). Alterations in the Mouse and Human Proteome Caused by Huntington’s Disease. Molecular & Cellular Proteomics, 1(5), 366–375.

Authors 7
  1. Claus Zabel (first)
  2. Daniel C. Chamrad (additional)
  3. Josef Priller (additional)
  4. Ben Woodman (additional)
  5. Helmut E. Meyer (additional)
  6. Gillian P. Bates (additional)
  7. Joachim Klose (additional)
References 78 Referenced 69
  1. {'key': '10.1074/mcp.M200016-MCP200_bib1', 'series-title': 'Huntington’s Disease', 'author': 'Harper', 'year': '1991'} / Huntington’s Disease by Harper (1991)
  2. 10.1016/0092-8674(93)90585-E / Cell. / A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes (1993)
  3. 10.1038/78054 / Nat. Genet. / Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity by Li (2000)
  4. 10.1006/exnr.1998.6832 / Exp. Neurol. / Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways by Velier (1998)
  5. 10.1126/science.1059581 / Science. / Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease by Zuccato (2001)
  6. 10.1016/S0092-8674(00)81369-0 / Cell. / Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice by Mangiarini (1996)
  7. 10.1523/JNEUROSCI.19-08-03248.1999 / J. Neurosci. / Characterization of progressive motor deficits in mice transgenic for the human Huntington’s disease mutation by Carter (1999)
  8. 10.1523/JNEUROSCI.19-23-10428.1999 / J. Neurosci. / Selective discrimination learning impairments in mice expressing the human Huntington’s disease mutation by Lione (1999)
  9. 10.1523/JNEUROSCI.20-13-05115.2000 / J. Neurosci. / Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington’s disease mutation by Murphy (2000)
  10. 10.1016/S0092-8674(00)80513-9 / Cell. / Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation by Davies (1997)
  11. 10.1073/pnas.95.11.6480 / Proc. Natl. Acad. Sci. U. S. A. / Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington’s disease gene by Cha (1998)
  12. 10.1016/S0306-4522(00)00157-3 / Neuroscience. / Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington’s disease mice by Denovan-Wright (2000)
  13. 10.1073/pnas.120166397 / Proc. Natl. Acad. Sci. U. S. A. / Severe deficiencies in dopamine signaling in presymptomatic Huntington’s disease mice by Bibb (2000)
  14. 10.1016/S0306-4522(00)00008-7 / Neuroscience. / The pattern of neurodegeneration in Huntington’s disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington’s disease by Glass (2000)
  15. 10.1016/0306-4522(95)00595-1 / Neuroscience. / Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington’s disease: a detailed cellular in situ hybridization study by Augood (1996)
  16. 10.1002/ana.410400110 / Ann. Neurol. / Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington’s disease by Weeks (1996)
  17. 10.1093/hmg/9.9.1259 / Hum. Mol. Genet. / Decreased expression of striatal signaling genes in a mouse model of Huntington’s disease by Luthi-Carter (2000)
  18. 10.1126/science.277.5334.1990 / Science. / Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain by DiFiglia (1997)
  19. 10.1093/hmg/8.7.1227 / Hum. Mol. Genet. / Ultrastructural localization and progressive formation of neuropil aggregates in Huntington’s disease transgenic mice by Li (1999)
  20. 10.1083/jcb.143.6.1457 / J. Cell Biol. / Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation by Perez (1998)
  21. 10.1073/pnas.96.20.11404 / Proc. Natl. Acad. Sci. U. S. A. / Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells by Kazantsev (1999)
  22. 10.1046/j.1365-2990.2000.00269.x / Neuropathol. Appl. Neurobiol. / Small heat shock proteins, the cytoskeleton, and inclusion body formation by Head (2000)
  23. 10.1038/502 / Nat. Genet. / Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 by Cummings (1998)
  24. 10.1073/pnas.100110097 / Proc. Natl. Acad. Sci. U. S. A. / The Huntington’s disease protein interacts with p53 and CREB-binding protein and represses transcription by Steffan (2000)
  25. 10.1126/science.1056784 / Science. / Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity by Nucifora (2001)
  26. 10.1093/hmg/9.13.2009 / Hum. Mol. Genet. / Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity by Jana (2000)
  27. 10.1016/S0002-9440(10)65409-0 / Am. J. Pathol. / Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by αB-crystallin by Koyama (1999)
  28. 10.1016/S0896-6273(00)80716-3 / Neuron. / Caspase-8 is required for cell death induced by expanded polyglutamine repeats by Sanchez (1999)
  29. 10.1073/pnas.140202897 / Proc. Natl. Acad. Sci. U. S. A. / Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils by Muchowski (2000)
  30. {'key': '10.1074/mcp.M200016-MCP200_bib30', 'first-page': '1743', 'article-title': 'Overexpression and abnormal modification of the stress proteins αB-crystallin and HSP27 in Alexander disease', 'volume': '143', 'author': 'Head', 'year': '1993', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / Overexpression and abnormal modification of the stress proteins αB-crystallin and HSP27 in Alexander disease by Head (1993)
  31. {'key': '10.1074/mcp.M200016-MCP200_bib31', 'first-page': '345', 'article-title': 'Accumulation of αB-crystallin in central nervous system glia and neurons in pathologic conditions', 'volume': '140', 'author': 'Iwaki', 'year': '1992', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / Accumulation of αB-crystallin in central nervous system glia and neurons in pathologic conditions by Iwaki (1992)
  32. 10.1097/00005072-198511000-00003 / J. Neuropathol. Exp. Neurol. / Neuropathological classification of Huntington’s disease by Vonsattel (1985)
  33. 10.1007/BF00296185 / Acta Neuropathol. / Expression of αB-crystallin in Alzheimer’s disease by Renkawek (1994)
  34. 10.1073/pnas.110078997 / Proc. Natl. Acad. Sci. U. S. A. / Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington’s disease by Turmaine (2000)
  35. 10.1038/ng0297-197 / Nat. Genet. / Instability of highly expanded CAG repeats in mice transgenic for the Huntington’s disease mutation by Mangiarini (1997)
  36. {'key': '10.1074/mcp.M200016-MCP200_bib36', 'first-page': '67', 'article-title': 'Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis', 'volume': '112', 'author': 'Klose', 'year': '1999', 'journal-title': 'Methods Mol. Biol.'} / Methods Mol. Biol. / Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis by Klose (1999)
  37. {'key': '10.1074/mcp.M200016-MCP200_bib37', 'first-page': '147', 'article-title': 'Large-gel 2-D electrophoresis', 'volume': '112', 'author': 'Klose', 'year': '1999', 'journal-title': 'Methods Mol. Biol.'} / Methods Mol. Biol. / Large-gel 2-D electrophoresis by Klose (1999)
  38. 10.1002/elps.11501601175 / Electrophoresis. / Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome by Klose (1995)
  39. 10.1002/elps.1150190607 / Electrophoresis. / Peptide mass fingerprint sequence coverage from differently stained proteins on two-dimensional electrophoresis patterns by matrix assisted laser desorption/ionization-mass spectrometry (MALDI-MS) by Scheler (1998)
  40. 10.1038/ng861 / Nat. Genet. / Genetic analysis of the mouse brain proteome by Klose (2002)
  41. 10.1002/1522-2683(200105)22:9<1669::AID-ELPS1669>3.0.CO;2-7 / Electrophoresis. / Identification of post-translationally modified proteins in proteome studies by Sickmann (2001)
  42. 10.1002/elps.1150170513 / Electrophoresis. / Structural analysis and identification of gel-purified proteins, available in the femtomole range, using a novel computer program for peptide sequence assignment, by matrix-assisted laser desorption ionization-reflectron time-of-flight-mass spectrometry by Gevaert (1996)
  43. 10.1021/ac991363o / Anal. Chem. / ProFound: an expert system for protein identification using mass spectrometric peptide mapping information by Zhang (2000)
  44. 10.1016/1044-0305(94)80016-2 / J. Am. Soc. Mass Spectrom. / An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database by Eng (1994)
  45. 10.1093/hmg/8.5.813 / Hum. Mol. Genet. / Formation of polyglutamine inclusions in non-CNS tissue by Sathasivam (1999)
  46. 10.1016/0378-1119(82)90158-5 / Gene. / Variation in mouse major urinary protein (MUP) genes and the MUP gene products within and between inbred lines by Clissold (1982)
  47. 10.1002/(SICI)1522-2683(19990701)20:10<2100::AID-ELPS2100>3.0.CO;2-D / Electrophoresis. / Proteomics in human disease: cancer, heart and infectious diseases by Jungblut (1999)
  48. 10.1016/0167-5699(94)90137-6 / Immunol. Today. / The acute phase response by Baumann (1994)
  49. 10.1146/annurev.bi.52.070183.003255 / Annu. Rev. Biochem. / Human plasma proteinase inhibitors by Travis (1983)
  50. 10.1097/00001756-199202000-00020 / Neuroreport. / α1-Antitrypsin and α1-antichymotrypsin are in the lesions of Alzheimer’s disease by Gollin (1992)
  51. 10.1111/j.1460-9568.1997.tb01425.x / Eur. J. Neurosci. / Serpins inhibit the toxicity of amyloid peptides by Schubert (1997)
  52. 10.1074/jbc.M008503200 / J. Biol. Chem. / α1-Proteinase inhibitor, α1-antichymotrypsin, and α2-macroglobulin are the antiapoptotic factors of vascular smooth muscle cells by Ikari (2001)
  53. 10.1161/01.CIR.102.12.1420 / Circulation. / Functional protection by acute phase proteins α(1)-acid glycoprotein and α(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation by Daemen (2000)
  54. 10.1016/0014-4800(68)90042-7 / Exp. Mol. Pathol. / Experimental hepatitis induced by @@ce:small-cap@@d@@/ce:small-cap@@-galactosamine by Keppler (1968)
  55. 10.1038/77528 / Nat. Med. / Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington’s disease by Chen (2000)
  56. 10.4049/jimmunol.163.10.5235 / J. Immunol. / Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins by Van Molle (1999)
  57. 10.1016/S0009-8981(97)00090-9 / Clin. Chim. Acta. / Albumin contamination of a purified human α1-antitrypsin preparation does not affect either structural conformation or the electrophoretic mobility of the inhibitor by Finotti (1997)
  58. 10.1038/311175a0 / Nature. / Plasma protease inhibitors in mouse and man: divergence within the reactive centre regions by Hill (1984)
  59. 10.1073/pnas.88.21.9417 / Proc. Natl. Acad. Sci. U. S. A. / Multiple murine α1-protease inhibitor genes show unusual evolutionary divergence by Borriello (1991)
  60. 10.1074/jbc.R100016200 / J. Biol. Chem. / The serpins are an expanding superfamily of structurally similar but functionally diverse proteins - evolution, mechanism of inhibition, novel functions, and a revised nomenclature by Silverman (2001)
  61. 10.1093/oxfordjournals.molbev.a025778 / Mol. Biol. Evol. / Expression of the α1-proteinase inhibitor gene family during evolution of the genus Mus by Goodwin (1997)
  62. 10.1016/S0021-9258(18)34943-3 / J. Biol. Chem. / Mouse plasma trypsin inhibitors. Isolation and characterization of α-1-antitrypsin and contrapsin, a novel trypsin inhibitor by Takahara (1982)
  63. 10.1006/abbi.1997.0317 / Arch. Biochem. Biophys. / Differential effects of heparin and glucose on structural conformation of human α1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor by Finotti (1997)
  64. 10.1073/pnas.89.21.10449 / Proc. Natl. Acad. Sci. U. S. A. / α-crystallin can function as a molecular chaperone by Horwitz (1992)
  65. 10.1073/pnas.88.9.3652 / Proc. Natl. Acad. Sci. U. S. A. / αB-crystallin is a small heat shock protein by Klemenz (1991)
  66. {'key': '10.1074/mcp.M200016-MCP200_bib66', 'first-page': '1083', 'article-title': 'Expression of the murine αB-crystallin gene is not restricted to the lens', 'volume': '9', 'author': 'Dubin', 'year': '1989', 'journal-title': 'Mol. Cell. Biol.'} / Mol. Cell. Biol. / Expression of the murine αB-crystallin gene is not restricted to the lens by Dubin (1989)
  67. 10.1016/S0165-5728(99)00260-X / J. Neuroimmunol. / Differential expression of stress proteins in human adult astrocytes in response to cytokines by Bajramovic (2000)
  68. 10.1002/ijc.2910550511 / Int. J. Cancer. / Expression of αB-crystallin in human brain tumors by Aoyama (1993)
  69. 10.1074/jbc.M104140200 / J. Biol. Chem. / Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation by Zhou (2001)
  70. 10.1016/S0167-4838(00)00149-7 / Biochim. Biophys. Acta. / Major urinary proteins, α(2U)-globulins and aphrodisin by Cavaggioni (2000)
  71. 10.3181/00379727-48-13332 / Proc. Soc. Exp. Biol. Med. by Wicks (1941)
  72. 10.1007/BF01923448 / Mus musculus. Experientia. / Pheromone binding proteins of the mouse, by Bacchini (1992)
  73. 10.1007/PL00000880 / Cell. Mol. Life Sci. / The vomeronasal system by Brennan (2001)
  74. 10.1006/anbe.1997.0650 / Anim. Behav. / Proteins in urine scent marks of male house mice extend the longevity of olfactory signals by Hurst (1998)
  75. 10.1023/A:1005578911652 / J. Chem. Ecol. / Stimulation of estrus in female mice by male urinary proteins by Marchlewska-Koj (2000)
  76. 10.1038/414631a / Nature. / Individual recognition in mice mediated by major urinary proteins by Hurst (2001)
  77. 10.1161/01.STR.32.3.753 / Stroke. / Acute-phase proteins before cerebral ischemia in stroke-prone rats: identification by proteomics by Sironi (2001)
  78. 10.1038/ng0597-44 / Nat. Genet. / HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain by Kalchman (1997)
Dates
Type When
Created 22 years, 5 months ago (April 2, 2003, 4:49 p.m.)
Deposited 2 years, 4 months ago (April 25, 2023, 10:14 p.m.)
Indexed 1 month, 4 weeks ago (July 7, 2025, 1:25 a.m.)
Issued 23 years, 4 months ago (May 1, 2002)
Published 23 years, 4 months ago (May 1, 2002)
Published Print 23 years, 4 months ago (May 1, 2002)
Funders 0

None

@article{Zabel_2002, title={Alterations in the Mouse and Human Proteome Caused by Huntington’s Disease}, volume={1}, ISSN={1535-9476}, url={http://dx.doi.org/10.1074/mcp.m200016-mcp200}, DOI={10.1074/mcp.m200016-mcp200}, number={5}, journal={Molecular &amp; Cellular Proteomics}, publisher={Elsevier BV}, author={Zabel, Claus and Chamrad, Daniel C. and Priller, Josef and Woodman, Ben and Meyer, Helmut E. and Bates, Gillian P. and Klose, Joachim}, year={2002}, month=may, pages={366–375} }